Women and coronary heart disease

Drug and Therapeutics Bulletin

Volumn 34, Issue 4, 1996, Pages 28-30

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ETHNIC DIFFERENCE; EXERCISE; FEMALE; FIBRINOLYTIC THERAPY; GENETIC PREDISPOSITION; HEART REHABILITATION; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MENOPAUSE; MORBIDITY; MORTALITY; OBESITY; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; SOCIAL CLASS; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029939427     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1996.34428     Document Type: Short Survey

References (42)

1. Health of the Nation Working Group. Variations in health. What can the Department of Health and the NHS do? London: Department of Health, 1995.
2. Office of Population Censuses and Surveys. Mortality Statistics. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1995. London: HMSO, 1994
3. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332: 1758-66.
4. Brezinka V, Padmos I. Coronary heart disease risk factors in women. Eur Heart J 1994; 15: 1571-84.
5. Khaw K-T. Where are the women in studies of coronary heart disease? BMJ 1993; 306: 1145-6.
6. Parish S, Collins R, Peto R et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14 000 cases and 32 000 controls in the United Kingdom. BMJ 1995; 311: 471-7.
7. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990; 322: 213-7.
8. Kitler ME. Coronary disease: are there gender differences? Eur Heart J 1994; 15: 409-17.
9. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
10. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995; 346: 1467-71.
11. Isles CG, Hole DJ, Hawthome VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 1992; 339: 702-6
12. Kaplan NM. The treatment of hypertension in women. Arch Intern Med 1995; 155: 563-7.
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
14. Manson JE, Willen WC, Stampfer MJ et al. Body weight and mortality among women. N Engl J Med 1995, 333: 677-85
15. Woodward M, Tunstall-Pedoe H. Alcohol consumption, diet, coronary risk factors, and prevalent coronary heart disease in men and women in the Scottish heart health study. J Epidemiol Community Health 1995; 49: 354-62.
16. Pekkanen J, Tuomilehto J, Uutela A, Vartiainen E, Nissinen A. Social class, health behaviour, and mortality among men and women in eastern Finland BMJ 1995; 311: 589-93.
17. Keil JE, Sutherland SE. Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 1993, 329: 73-8.
18. Bhatnagar D, Anand IS, Durrington PN et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995, 345: 405-9
19. Lewis MA, Spitzer WO. Heinemann LAJ, MacRae KD, Bruppacher R, Thorogood M Third generation oral contraceptives and risk of myocardial infarction: an international case-control study, BMJ 1996; 312: 88-90.
20. Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996; 312: 83-8.
21. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Int Med 1978; 89: 157-61
22. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83-90.
23. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325: 756-62.
24. Folsom AR, Mink PJ, Sellers TA, Hong C-P, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995; 85: 1128-32.
25. Falkeborn M, Persson I, Adami H-O et al. The risk of acute myocaridal infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821-8.
26. Psaty BM, Heckbert SR, Atkins D et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 1994, 154: 1333-9.
27. Colditz GA, Hankinson SE, Hunter DJ et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl Med 1995; 332: 1589-93.
28. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274: 137-42.
29. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993; 329: 247-56.
30. Lip GYH, Beevers M, Churchill D, Beevers DG. Do clinicians prescribe HRT for hypertensive postmenopausal women? Br J Clin Pract 1995; 49: 61-4.
31. Jackson G. Coronary artery disease and women. BMJ 1994; 309: 555-7.
32. Sullivan AK, Holdright DR, Wrighr CA, Sparrow JL, Cunningham D, Fox KM. Chest pain in women: clinical, investigative and prognostic features. BMJ 1994; 308: 883-6.
33. Roger VL. Stress testing for the diagnosis of coronary artery disease in women. ACC Current Journal Review 1995; May/June: 31-3.
34. Cerqueira MD. Diagnostic testing strategies for coronary artery disease: special issues related to gender. Am J Cordiol 1995; 75: 52-60D.
35. Adams JN, Jamieson M, Rawles JM, Trent RJ, Jennings KP. Women and myocardial infarction: agism rather than sexism? Br Heart J 1995; 73: 87-91.
36. Fibrinolytic Therapy Trialists' (FIT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
37. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
38. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-60.
39. Clarke KW, Gray D, Kearing NA, Hampton JR. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994; 309: 563-6.
40. Barbir M, Lazem F, Ilsley C, Mitchell A, Khaghani A, Yacoub M. Coronary artery surgery in women compared with men: analysis of coronary risk factors and in-hospital mortality in a single centre. Br Heart J 1994; 71: 408-12.
41. Arnold AM, Mick MJ, Piedmonte MR, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol 1994; 74: 18-21.
42. McGee HM, Horgan JH. Cardiac rehabilitation programmes: are women less likely to attend? BMJ 1992; 305: 283-4.